LC

Lineage Cell Therapeutics IncNYSE-MKT LCTX Stock Report

Last reporting period 30 Jun, 2024

Updated 08 Nov, 2024

Last price

Market cap $B

0.169

Micro

Exchange

XASE - Nyse MKT LLC

View Full Company Analysis

Lineage Current ratio

2.5

Last period Current ratio

-43%

Current ratio has decreased in 5 years


What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio ?

Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.

What is Current ratio of Lineage Cell ?

Lineage Cell`s Current ratio for the last twelve months ended 2024-06-30 is 2.5

View Full Company Analysis